Medications

Defect prompts Mylan to recall some Epipens

(HealthDay)—Mylan, the maker of the Epipen, says it is recalling "select lots" of the device used to treat dangerous allergic reactions due to a defect that might render it "difficult to activate in an emergency."

Medications

Mylan launching cheaper, generic version of EpiPen

The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.

Diseases, Conditions, Syndromes

Anaphylactic shock after vaccination 'extremely rare'

A sudden, serious allergic reaction -- known anaphylaxis or anaphylactic shock -- following vaccination, is "extremely rare," concludes research published online in the Archives of Disease in Childhood.

page 2 from 2